These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10546922)

  • 1. Pharmacokinetics and pharmacodynamics of dichloroacetate in patients with cirrhosis.
    Shangraw RE; Fisher DM
    Clin Pharmacol Ther; 1999 Oct; 66(4):380-90. PubMed ID: 10546922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of sodium dichloroacetate in endotoxemic minipigs.
    Weingand KW; Fettman MJ; Phillips RW; Hand MS
    Circ Shock; 1986; 19(1):55-67. PubMed ID: 3521930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects.
    Rasmussen BM; Orskov L; Schmitz O; Hermansen K
    Metabolism; 2001 Apr; 50(4):451-7. PubMed ID: 11288041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
    Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
    Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyrone metabolism in liver disease.
    Zylber-Katz E; Caraco Y; Granit L; Levy M
    Clin Pharmacol Ther; 1995 Aug; 58(2):198-209. PubMed ID: 7648770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo metabolic response of glucose to dichloroacetate in humans.
    Brown JA; Gore DC
    J Surg Res; 1996 Mar; 61(2):391-4. PubMed ID: 8656614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
    Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R
    Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of postprandial hyperglycemia in liver transplant recipients: comparison of liver transplant patients with kidney transplant patients and healthy controls.
    Schneiter P; Gillet M; Chioléro R; Jéquier E; Mosimann F; Temler E; Téta D; Matter M; Wauters JP; Tappy L
    Diabetes Metab; 2000 Feb; 26(1):51-6. PubMed ID: 10705104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of dichloroacetate-induced hypolactatemia in humans with or without cirrhosis.
    Shangraw RE; Jahoor F
    Metabolism; 2004 Aug; 53(8):1087-94. PubMed ID: 15281024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of serum lactate by sodium dichloroacetate, and human pharmacokinetic-pharmacodynamic relationships.
    Fox AW; Sullivan BW; Buffini JD; Neichin ML; Nicora R; Hoehler FK; O'Rourke R; Stoltz RR
    J Pharmacol Exp Ther; 1996 Nov; 279(2):686-93. PubMed ID: 8930172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
    Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
    Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.
    Bahr MJ; Boeker KH; Manns MP; Tietge UJ
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):60-5. PubMed ID: 18466349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of liver disease on urine caffeine metabolite ratios.
    Denaro CP; Wilson M; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1996 Jun; 59(6):624-35. PubMed ID: 8681487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation.
    Tietge UJ; Bahr MJ; Manns MP; Böker KH
    Liver Transpl; 2001 Dec; 7(12):1015-22. PubMed ID: 11753903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
    Fabbri A; Marchesini G; Bianchi G; Bugianesi E; Bortoluzzi L; Zoli M; Pisi E
    Hepatology; 1993 Jul; 18(1):28-35. PubMed ID: 8325618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation.
    Tietge UJ; Bahr MJ; Manns MP; Böker KH
    Transplantation; 2003 Mar; 75(6):804-10. PubMed ID: 12660506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis.
    Ruan P; Gong ZJ; Zhang QR
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):58-61. PubMed ID: 14969839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.